European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab November 18, 2025 Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1 The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2 The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20% 1,3 Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency 3
Wealthy divorcees race to leave Britain before the Budget November 18, 2025 High net worth divorcees are rushing to relocate amid rumours of wealth taxes and a raid on international assets, but it’s more complicated than they think, says Sophie Chapman Conflict resolution is a growth area and England (London in particular) undoubtedly remains a magnet for wealthy international couples seeking to resolve their disputes. Recent decisions [...]
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg November 18, 2025 Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in Europe Omlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence
British Basketball Federation ignored warnings before liquidation, says SLB owner November 17, 2025 The owner of Manchester Basketball has accused the British Basketball Federation of failing to heed the warning of Super League Basketball clubs before its collapse into liquidation. The governing body, which was responsible for running the Great Britain national teams and securing UK Sport funding for its elite programmes, appointed an insolvency firm last week. [...]
Duravant Announces Retirement of CEO Mike Kachmer, Names Jill Evanko Successor November 17, 2025 Mike Kachmer to retire following a distinguished 43-year career, including nearly 12 years as Chairman & CEO of Duravant Jill Evanko to succeed Mr. Kachmer as Duravant’s Chief Executive Officer
87% of Institutional Investors Have Declined or Reconsidered Fund Commitments Due to AML/KYC Concerns November 17, 2025 63% of GPs say they have lost investors or reinvestments due to AML/KYC compliance shortcomings 88% of LPs are more likely to invest in a manager with a formal AML/KYC program Nearly three-quarters of GPs report cost savings of 10-30% from outsourcing AML/KYC functions to dedicated specialists
Cloudflare to Acquire Replicate to Build the Most Seamless AI Cloud for Developers November 17, 2025 Acquisition will enable quick and easy deployment of any AI model to millions of Cloudflare users worldwide
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization November 17, 2025 Broken String Biosciences (“Broken String”), a leader in advancing gene editing safety, today announced the appointment of new leadership to drive the commercialization of its INDUCE-seq® platform, now available to cell and gene therapy developers worldwide. To drive the company’s commercial expansion, Terry Pizzie has been appointed as CEO, bringing extensive experience from leading and [...]
Hyundai Ioniq 5 N 2025 review: Electric that pretends to be petrol November 17, 2025 As many a YouTube drag race can attest, electric cars aren’t deficient when it comes to straight-line speed. After that sugar-rush of giddy acceleration wears off, though, you may be left feeling empty and unsatisfied. Going fast doesn’t necessarily equate to having fun. Many believe that EVs are too heavy and too complicated, smothering the [...]
MSCI Announces Baer Pettit to Retire as President November 17, 2025 Additional senior leadership changes will drive growth in new client segments and products